Pyroptosis-Related Genes as Diagnostic Markers in Chronic Obstructive Pulmonary Disease and Its Correlation with Immune Infiltration
International Journal of Chronic Obstructive Pulmonary Disease · 2024
DOI: 10.2147/copd.s438686 ↗At a glance
Journal article in International Journal of Chronic Obstructive Pulmonary Disease, 2024. Written by Hong-Mei Shu and 9 co-authors. Institution: Department of Pulmonary and Critical Care Medicine, Anqing Municipal Hospital, Anhui, People's Republic of China. Major MEDLINE topics: Pulmonary Disease, Chronic Obstructive, Pyroptosis, Databases, Genetic, Predictive Value of Tests. Cited 9 times so far (Crossref); 68 references. The full text is freely available (open access, CC BY-NC 3.0). Funded by: Health Research Program of Anhui, Anhui Provincial Key Research and Development Project.
Topics: COPD
Abstract (original language)
Background
Chronic obstructive pulmonary disease (COPD) stands as a predominant cause of global morbidity and mortality. This study aims to elucidate the relationship between pyroptosis-related genes (PRGs) and COPD diagnosis in the context of immune infiltration, ultimately proposing a PRG-based diagnostic model for predicting COPD outcomes.
Methods
Clinical data and PRGs of COPD patients were sourced from the GEO database. The "ConsensusClusterPlus" package was employed to generate molecular subtypes derived from PRGs that were identified through differential expression analysis and LASSO Cox analysis. A diagnostic signature including eight genes (CASP4, CASP5, ELANE, GPX4, NLRP1, GSDME, NOD1and IL18) was also constructed. Immune cell infiltration calculated by the ESTIMATE score, Stroma scores and Immune scores were also compared on the basis of pyroptosis-related molecular subtypes and the risk signature. We finally used qRT - PCR to detect the expression levels of eight genes in COPD patient and normal.
Results
The diagnostic model, anchored on eight PRGs, underwent validation with an independent experimental cohort. The area under the receiver operating characteristic (ROC) curves (AUC) for the diagnostic model showcased values of 0.809, 0.765, and 0.956 for the GSE76925, GSE8545, and GSE5058 datasets, respectively. Distinct expression patterns and clinical attributes of PRGs were observed between the comparative groups, with functional analysis underscoring a disparity in immune-related functions between them.
Conclusion
In this study, we developed a potential as diagnostic biomarkers for COPD and have a significant role in modulating the immune response. Such insights pave the way for novel diagnostic and therapeutic strategies for COPD.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pulmonary and Critical Care Medicine, Anqing Municipal Hospital, Anhui, People's Republic of China.
- Neurosurgery Department, Anqing Municipal Hospital, Anhui, People's Republic of China.
ORCID profiles: Hong-Mei Shu, Wang Wang
Funding
- Health Research Program of Anhui
- Anhui Provincial Key Research and Development Project
Cite
APA
Shu, H. M., Lin, C. Q., He, B., Wang, W., Wang, L., Wu, T., He, H. J., Wang, H. J., Zhou, H. P., & Ding, G. Z. (2024). Pyroptosis-Related Genes as Diagnostic Markers in Chronic Obstructive Pulmonary Disease and Its Correlation with Immune Infiltration. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s438686
Vancouver
Shu HM, Lin CQ, He B, Wang W, Wang L, Wu T, et al. Pyroptosis-Related Genes as Diagnostic Markers in Chronic Obstructive Pulmonary Disease and Its Correlation with Immune Infiltration. International Journal of Chronic Obstructive Pulmonary Disease. 2024. doi:10.2147/copd.s438686
BibTeX
@article{Shu2024,
author = {Shu, Hong-Mei and Lin, Chang-Qing and He, Bei and Wang, Wang and Wang, Ling and Wu, Ting and He, Hai-Juan and Wang, Hui-Juan and Zhou, He-Ping and Ding, Guo-Zheng},
title = {Pyroptosis-Related Genes as Diagnostic Markers in Chronic Obstructive Pulmonary Disease and Its Correlation with Immune Infiltration},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2024},
doi = {10.2147/copd.s438686}
}
EUVIMED